Max Healthcare Reports Mixed Financial Results for Q2 2024, Stock Given 'Hold' Rating

Nov 07 2024 04:52 PM IST
share
Share Via
Max Healthcare Institute, a leading healthcare provider, reported a negative performance in the second quarter of fiscal year 2024-2025 with a score of -7, an improvement from the previous quarter. Net sales were at an all-time high of Rs 1,707.46 crore, showing a positive trend. However, operating profit to interest ratio has been consistently falling and debt levels are increasing, indicating areas for improvement. Investors are advised to hold their stock and monitor the company's ability to manage its interest payments and debt levels.

Max Healthcare Institute, a leading hospital and healthcare services provider, recently announced its financial results for the quarter ending September 2024. The company's stock has been given a 'Hold' call by MarketsMOJO.

According to the financial report, Max Healthcare has seen a negative performance in the second quarter of the fiscal year 2024-2025, with a score of -7. However, this is an improvement from the previous quarter's score of -11.

The company's net sales for the quarter were at an all-time high of Rs 1,707.46 crore, showing a positive trend in the near term. This is a growth of 20.6% over the average net sales of the previous four quarters, which were at Rs 1,416.00 crore.

Max Healthcare's operating profit (PBDIT) for the quarter was also at its highest in the last five quarters, at Rs 450.54 crore. The profit before tax (PBT) less other income was also at its highest in the last five quarters, at Rs 332.85 crore. This shows a positive trend in the near term for the company.

However, there are some areas that need improvement for Max Healthcare. The company's operating profit to interest ratio has been consistently falling in the last five quarters, with the latest being at its lowest at 13.43 times. This indicates a deteriorating ability to manage interest payments.

The interest cost for the quarter has also increased by 40.45% quarter on quarter, which signifies increased borrowings. The debt-equity ratio for the last five half yearly periods has been at its highest at 0.20 times, indicating that the company is borrowing more to fund its operations and its liquidity situation may be stressed.

Additionally, the company's debtors turnover ratio for the last five half yearly periods has been at its lowest at 11.36 times, showing a slowdown in the pace of settling its debtors.

Overall, Max Healthcare's financial performance for the quarter ending September 2024 has been a mix of positive and negative trends. Investors are advised to hold their stock and keep an eye on the company's ability to manage its interest payments and debt levels.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News